Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

The Lymphotoxin β Receptor Is Essential for Upregulation of IFN-Induced Guanylate-Binding Proteins and Survival after Toxoplasma gondii Infection.

Behnke K, Sorg UR, Gabbert HE, Pfeffer K.

Mediators Inflamm. 2017;2017:7375818. doi: 10.1155/2017/7375818. Epub 2017 Aug 6.

2.

Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?

Schimmöller L, Quentin M, Blondin D, Dietzel F, Hiester A, Schleich C, Thomas C, Rabenalt R, Gabbert HE, Albers P, Antoch G, Arsov C.

Eur Radiol. 2016 Nov;26(11):3858-3864. Epub 2016 Feb 26.

PMID:
26920391
3.

Cooperative role of lymphotoxin β receptor and tumor necrosis factor receptor p55 in murine liver regeneration.

Sorg UR, Behnke K, Degrandi D, Reich M, Keitel V, Herebian D, Deenen R, Beyer M, Schultze JL, Köhrer K, Gabbert HE, Mayatepek E, Häussinger D, Pfeffer K.

J Hepatol. 2016 May;64(5):1108-1117. doi: 10.1016/j.jhep.2015.12.006. Epub 2015 Dec 19.

PMID:
26708145
4.

Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.

Mersch S, Riemer JC, Schlünder PM, Ghadimi MP, Ashmawy H, Möhlendick B, Topp SA, Arent T, Kröpil P, Stoecklein NH, Gabbert HE, Knoefel WT, Krieg A.

Tumour Biol. 2016 Feb;37(2):2341-51. doi: 10.1007/s13277-015-4050-6. Epub 2015 Sep 15.

PMID:
26373732
5.

Discovery of Novel, Potent, and Specific Cell-Death Inducers in the Jurkat Acute Lymphoblastic Leukemia Cell Line.

Carosati E, van den Höfel N, Reif M, Randazzo GM, Stanitzki B, Stevens J, Gabbert HE, Cruciani G, Mannhold R, Mahotka C.

ChemMedChem. 2015 Oct;10(10):1700-6. doi: 10.1002/cmdc.201500245. Epub 2015 Aug 12.

PMID:
26267799
6.

Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.

Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, Gabbert HE, Becker N, Antoch G, Albers P, Schimmöller L.

Eur Urol. 2015 Oct;68(4):713-20. doi: 10.1016/j.eururo.2015.06.008. Epub 2015 Jun 23.

PMID:
26116294
7.

CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.

Krieg A, Riemer JC, Telan LA, Gabbert HE, Knoefel WT.

PLoS One. 2015 Jun 19;10(6):e0130192. doi: 10.1371/journal.pone.0130192. eCollection 2015.

8.

The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy.

Arsov C, Becker N, Rabenalt R, Hiester A, Quentin M, Dietzel F, Antoch G, Gabbert HE, Albers P, Schimmöller L.

J Cancer Res Clin Oncol. 2015 Nov;141(11):2061-8. doi: 10.1007/s00432-015-1991-5. Epub 2015 May 27.

PMID:
26013424
9.

[Neuroendocrine neoplasms of the breast].

Anlauf M, Neumann M, Bomberg S, Luczak K, Heikaus S, Gustmann C, Antke C, Ezziddin S, Fottner C, Pavel M, Pape UF, Rinke A, Lahner H, Schott M, Cremer B, Hörsch D, Baum RP, Groh U, Alkatout I, Rudlowski C, Scheler P, Zirbes TK, Hoffmann J, Fehm T, Gabbert HE, Baldus SE.

Pathologe. 2015 May;36(3):261-70. doi: 10.1007/s00292-015-0024-0. Review. German.

PMID:
25986886
10.

Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.

Deml KF, Schildhaus HU, Compérat E, von Teichman A, Storz M, Schraml P, Bonventre JV, Fend F, Fleige B, Nerlich A, Gabbert HE, GaBler N, Grobholz R, Hailemariam S, Hinze R, Knüchel R, Lhermitte B, Nesi G, Rüdiger T, Sauter G, Moch H.

Am J Surg Pathol. 2015 Jul;39(7):889-901. doi: 10.1097/PAS.0000000000000456.

11.

[Waldemar Hort: 08.05.1925-05.06.2014].

Gabbert HE.

Pathologe. 2014 Nov;35 Suppl 2:307. doi: 10.1007/s00292-014-1972-5. German. No abstract available.

PMID:
25394985
12.

[Neuroendocrine neoplasms of the distal jejunum and ileum].

Anlauf M, Sipos B, Boeck I, Baldus SE, Heikaus S, Krausch M, Knoefel WT, Begum N, Goretzki P, Schott M, Auernhammer CJ, Cremer B, Rinke A, Ezziddin S, Fottner C, Pöpperl G, Lahner H, Hörsch D, Gabbert HE, Komminoth P, Perren A, Klöppel G, Wiedenmann B, Pavel M, Pape U.

Pathologe. 2014 May;35(3):283-93; quiz 294. doi: 10.1007/s00292-013-1888-5. Review. German.

PMID:
24671468
13.

Expression of TRAIL-splice variants in gastric carcinomas: identification of TRAIL-γ as a prognostic marker.

Krieg A, Mersch S, Wolf N, Stoecklein NH, Verde PE, am Esch JS 2nd, Heikaus S, Gabbert HE, Knoefel WT, Mahotka C.

BMC Cancer. 2013 Aug 12;13:384. doi: 10.1186/1471-2407-13-384.

14.

KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines.

Messner I, Cadeddu G, Huckenbeck W, Knowles HJ, Gabbert HE, Baldus SE, Schaefer KL.

J Cancer Res Clin Oncol. 2013 Feb;139(2):201-9. doi: 10.1007/s00432-012-1319-7. Epub 2012 Sep 27.

PMID:
23015072
15.

EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.

Geddert H, zur Hausen A, Gabbert HE, Sarbia M.

Cell Oncol (Dordr). 2011 Jun;34(3):209-14. doi: 10.1007/s13402-011-0028-6. Epub 2011 May 3.

PMID:
21538028
16.

Daxx-beta and Daxx-gamma, two novel splice variants of the transcriptional co-repressor Daxx.

Wethkamp N, Hanenberg H, Funke S, Suschek CV, Wetzel W, Heikaus S, Grinstein E, Ramp U, Engers R, Gabbert HE, Mahotka C.

J Biol Chem. 2011 Jun 3;286(22):19576-88. doi: 10.1074/jbc.M110.196311. Epub 2011 Apr 10.

17.

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P, Baretton G, Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer WA, Dietrich CF, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert HE, Galle PR, Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann JT, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz RD, Höfler H, Höhler T, Hölscher AH, Horneber M, Hübner J, Izbicki JR, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J, Krause BJ, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel S, Messmann H, Meyer HJ, Mönig S, Piso P, Pistorius S, Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp W, Schlag PM, Schmid RM, Schmidberger H, Schmiegel WH, Schmoll HJ, Schuch G, Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H, Wittekind C; AWMF; AWMF.

Z Gastroenterol. 2011 Apr;49(4):461-531. doi: 10.1055/s-0031-1273201. Epub 2011 Apr 7. German. No abstract available.

PMID:
21476183
18.

EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.

Geddert H, Zur Hausen A, Gabbert HE, Sarbia M.

Anal Cell Pathol (Amst). 2010;33(3):143-9. doi: 10.3233/ACP-CLO-2010-0540.

19.

Regulation of p53 isoform expression in renal cell carcinoma.

van den Berg L, Segun AD, Mersch S, Blasberg N, Grinstein E, Wai D, Anlauf M, Gabbert HE, Mahotka C, Heikaus S.

Front Biosci (Elite Ed). 2010 Jun 1;2:1042-53.

PMID:
20515774
20.

Prospective comparison of endoscopic ultrasound-guided fine-needle aspiration and surgical histology in upper gastrointestinal submucosal tumors.

Philipper M, Hollerbach S, Gabbert HE, Heikaus S, Böcking A, Pomjanski N, Neuhaus H, Frieling T, Schumacher B.

Endoscopy. 2010 Apr;42(4):300-5. doi: 10.1055/s-0029-1244006. Epub 2010 Mar 19.

PMID:
20306384
21.

HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series.

Grabsch H, Sivakumar S, Gray S, Gabbert HE, Müller W.

Cell Oncol. 2010;32(1-2):57-65. doi: 10.3233/CLO-2009-0497.

22.

PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.

Heikaus S, Pejin I, Gabbert HE, Ramp U, Mahotka C.

Cell Oncol. 2010;32(1-2):29-42. doi: 10.3233/CLO-2009-0492.

23.

Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.

Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE.

Clin Cancer Res. 2010 Feb 1;16(3):790-9. doi: 10.1158/1078-0432.CCR-09-2446. Epub 2010 Jan 26.

24.

Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.

Erlic Z, Hoffmann MM, Sullivan M, Franke G, Peczkowska M, Harsch I, Schott M, Gabbert HE, Valimäki M, Preuss SF, Hasse-Lazar K, Waligorski D, Robledo M, Januszewicz A, Eng C, Neumann HP.

J Clin Endocrinol Metab. 2010 Jan;95(1):308-13. doi: 10.1210/jc.2009-1728. Epub 2009 Nov 11.

25.

Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.

Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U, Mackintosh C, de Alava E, Myklebost O, Kresse SH, Meza-Zepeda LA, Serra M, Cleton-Jansen AM, Hogendoorn PC, Buerger H, Aigner T, Gabbert HE, Poremba C.

Genes Chromosomes Cancer. 2010 Jan;49(1):40-51. doi: 10.1002/gcc.20717.

PMID:
19787792
26.

Immunohistochemical expression of epithelial cell markers in corneas with congenital aniridia and ocular cicatrizing pemphigoid.

Auw-Haedrich C, Agrawal M, Gabbert HE, Meyer P, Arnold N, Reinhard T.

Acta Ophthalmol. 2011 Feb;89(1):47-53. doi: 10.1111/j.1755-3768.2009.01603.x.

27.

Primary peripheral primitive neuroectodermal tumor/Ewing's tumor of the testis in a 46-year-old man-differential diagnosis and review of the literature.

Heikaus S, Schaefer KL, Eucker J, Hogrebe E, Danebrock R, Wai DH, Krenn V, Gabbert HE, Poremba C.

Hum Pathol. 2009 Jun;40(6):893-7. doi: 10.1016/j.humpath.2008.11.009. Epub 2009 Mar 9. Review.

PMID:
19269015
28.

Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers.

Rohrbeck A, Neukirchen J, Rosskopf M, Pardillos GG, Geddert H, Schwalen A, Gabbert HE, von Haeseler A, Pitschke G, Schott M, Kronenwett R, Haas R, Rohr UP.

J Transl Med. 2008 Nov 7;6:69. doi: 10.1186/1479-5876-6-69.

29.

Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas.

Shibata T, Noguchi T, Takeno S, Gabbert HE, Ramp U, Kawahara K.

Ann Surg Oncol. 2008 Dec;15(12):3579-87. doi: 10.1245/s10434-008-0062-4. Epub 2008 Sep 19.

PMID:
18807090
30.

HA14-1 is able to reconstitute the impaired mitochondrial pathway of apoptosis in renal cell carcinoma cell lines.

Heikaus S, van den Berg L, Kempf T, Mahotka C, Gabbert HE, Ramp U.

Cell Oncol. 2008;30(5):419-33.

31.

Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC.

Heikaus S, Kempf T, Mahotka C, Gabbert HE, Ramp U.

Apoptosis. 2008 Jul;13(7):938-49. doi: 10.1007/s10495-008-0225-6.

PMID:
18516683
32.

Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays.

Burchardt M, Engers R, Müller M, Burchardt T, Willers R, Epstein JI, Ackermann R, Gabbert HE, de la Taille A, Rubin MA.

J Cancer Res Clin Oncol. 2008 Oct;134(10):1071-8. doi: 10.1007/s00432-008-0388-0. Epub 2008 Apr 8.

PMID:
18392850
33.

[Prognostic and predictive impact of protein expression profiling in high risk breast cancer patients treated with high-dose chemotherapy].

Diallo-Danebrock R, Ting E, Gluz O, Herr A, Mohrmann S, Geddert H, Gabbert HE, Nitz U, Poremba C.

Verh Dtsch Ges Pathol. 2007;91:187-96. German.

PMID:
18314614
34.

Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.

Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Juergens H, Herrero D, Stegmaier S, Koscielniak E, Eggert A, Nathrath M, Gosheger G, Schneider DT, Bury C, Diallo-Danebrock R, Ottaviano L, Gabbert HE, Poremba C.

Eur J Cancer. 2008 Mar;44(5):699-709. doi: 10.1016/j.ejca.2008.01.020. Epub 2008 Feb 21.

PMID:
18294840
35.

Paclitaxel (Taxol)-induced apoptosis in human epithelioid sarcoma cell lines is enhanced by upregulation of CD95 ligand (FasL/Apo-1L).

Heikaus S, Matuszek KS, Suschek CV, Ramp U, Reinecke P, Grinstein E, Haremza J, Gabbert HE, Mahotka C.

J Cancer Res Clin Oncol. 2008 Jun;134(6):689-95. Epub 2007 Dec 12.

PMID:
18074150
36.

Biochip analysis: status quo.

Braun Y, Wai DH, Biemel K, Schäfer KL, Gabbert HE, Poremba C.

Verh Dtsch Ges Pathol. 2005;89:116-24.

PMID:
18035681
37.

C-kit expression in high-risk breast cancer subgroup treated with high-dose or conventional dose-dense chemotherapy.

Diallo R, Ting E, Gluz O, Herr A, Schütt G, Geddert H, Mohrmann S, Gabbert HE, Nitz U, Poremba C.

Verh Dtsch Ges Pathol. 2006;90:177-85.

PMID:
17867595
38.

Prognostic relevance of increased Rac GTPase expression in prostate carcinomas.

Engers R, Ziegler S, Mueller M, Walter A, Willers R, Gabbert HE.

Endocr Relat Cancer. 2007 Jun;14(2):245-56.

PMID:
17639041
39.

Expression of heat shock protein 70 in renal cell carcinoma and its relation to tumor progression and prognosis.

Ramp U, Mahotka C, Heikaus S, Shibata T, Grimm MO, Willers R, Gabbert HE.

Histol Histopathol. 2007 Oct;22(10):1099-107. doi: 10.14670/HH-22.1099.

PMID:
17616937
40.

Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas.

Heikaus S, Casliskan E, Mahotka C, Gabbert HE, Ramp U.

Apoptosis. 2007 Sep;12(9):1645-57.

PMID:
17610067
41.

Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression.

Alldinger I, Schaefer KL, Goedde D, Ottaviano L, Dirksen U, Ranft A, Juergens H, Gabbert HE, Knoefel WT, Poremba C.

J Cancer Res Clin Oncol. 2007 Oct;133(10):749-59. Epub 2007 May 25.

PMID:
17530287
42.

Disturbed expression of the apoptosis regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas.

Shibata T, Mahotka C, Wethkamp N, Heikaus S, Gabbert HE, Ramp U.

Diagn Mol Pathol. 2007 Mar;16(1):1-8.

PMID:
17471152
43.

Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy.

Diallo-Danebrock R, Ting E, Gluz O, Herr A, Mohrmann S, Geddert H, Rody A, Schaefer KL, Baldus SE, Hartmann A, Wild PJ, Burson M, Gabbert HE, Nitz U, Poremba C.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):488-97.

44.

Expression analysis of pancreatic cancer cell lines reveals association of enhanced gene transcription and genomic amplifications at the 8q22.1 and 8q24.22 loci.

Domagk D, Schaefer KL, Eisenacher M, Braun Y, Wai DH, Schleicher C, Diallo-Danebrock R, Bojar H, Roeder G, Gabbert HE, Domschke W, Poremba C.

Oncol Rep. 2007 Feb;17(2):399-407.

PMID:
17203180
45.

Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.

Rehfeld N, Geddert H, Atamna A, Gabbert HE, Steidl U, Fenk R, Kronenwett R, Haas R, Rohr UP.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2232-8.

46.

Prognostic relevance of Tiam1 protein expression in prostate carcinomas.

Engers R, Mueller M, Walter A, Collard JG, Willers R, Gabbert HE.

Br J Cancer. 2006 Oct 23;95(8):1081-6. Epub 2006 Sep 26.

47.

Rac upregulates tissue inhibitor of metalloproteinase-1 expression by redox-dependent activation of extracellular signal-regulated kinase signaling.

Engers R, Springer E, Kehren V, Simic T, Young DA, Beier J, Klotz LO, Clark IM, Sies H, Gabbert HE.

FEBS J. 2006 Oct;273(20):4754-69. Epub 2006 Sep 19.

48.

TRAIL-R4-beta: a new splice variant of TRAIL-receptor 4 lacking the cysteine rich domain 1.

Krieg A, Schulte am Esch J 2nd, Ramp U, Hosch SB, Knoefel WT, Gabbert HE, Mahotka C.

Biochem Biophys Res Commun. 2006 Oct 13;349(1):115-21. Epub 2006 Aug 14.

PMID:
16934748
49.

Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model.

Franzius C, Hotfilder M, Poremba C, Hermann S, Schäfers K, Gabbert HE, Jürgens H, Schober O, Schäfers M, Vormoor J.

Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1432-41. Epub 2006 Jul 29.

PMID:
16896672
50.

Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue.

Schaefer KL, Brachwitz K, Braun Y, Diallo R, Wai DH, Zahn S, Schneider DT, Kuhnen C, Vollmann A, Brockhoff G, Gabbert HE, Poremba C.

Neoplasia. 2006 Jul;8(7):613-22.

Supplemental Content

Loading ...
Support Center